Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

18,758 total articles

Beneficient Reports First Quarter Fiscal 2027 Results

Beneficient Reports First Quarter Fiscal 2027 Results

Beneficient, a Nasdaq-listed technology-enabled platform for alternative asset liquidity and capital solutions, reported its Q1 FY 2027 results showing progress in strategic initiatives. Key developments include securing its first collateral management services agreement with a Texas state-chartered bank, generating expected recurring fee revenue, …

Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance

Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance

Super League Enterprise, Inc. announced second quarter 2026 financial results showing sequential net revenue growth of 16%, gross margin expansion to 41%, and a 20% year-over-year improvement in adjusted EBITDA, despite flat gross revenue in a tough advertising environment. The company successfully integrated Misfits Ads assets without raising cost…

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

BridgeBio Pharma announced the pricing of a secondary offering of 5 million shares of common stock by selling shareholder KKR Genetic Disorder L.P. The company itself is not selling shares and will not receive proceeds from this transaction. The offering aims to diversify and evolve BridgeBio's institutional shareholder base toward long-term, high-…

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Outlook Therapeutics announced its Q3 fiscal 2026 financial results and detailed progress toward the U.S. commercial launch of LYTENAVA™, the only FDA-approved ophthalmic bevacizumab for wet age-related macular degeneration (wet AMD). The company aims to launch LYTENAVA in the U.S. by the end of 2026 and projects potential annual sales exceeding $5…

Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split

Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split

Beyond Meat, Inc. has completed a 1-for-30 reverse stock split effective August 13, 2026, reducing the number of outstanding shares and authorized shares to help the company meet Nasdaq's minimum bid price requirement. The adjusted shares will begin trading on August 14, 2026 under the ticker BYND. The reverse split proportionately adjusts conversi…

Teamshares Reports 2Q 2026 Results and Reaffirms 2026 Outlook

Teamshares Reports 2Q 2026 Results and Reaffirms 2026 Outlook

Teamshares announced Q2 2026 results showing 20% revenue growth to $148.7 million, net income of $9.5 million, and a 166% increase in Adjusted EBITDA year-over-year. The company reaffirmed its 2026 full-year outlook with a $40 million EBITDA acquisition target, underpinned by a strong pipeline including $30 million annual EBITDA under letters of in…

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Adlai Nortye Ltd. reported strong operational progress with ongoing enrollment in global Phase I trials for its pan-RAS(ON) inhibitor AN9025 and regulatory approval for Phase I trial of AN4035 ADC. The company raised a total of $290 million in equity financing in early 2026, significantly boosting its cash reserves. Financial results show increased…

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Fate Therapeutics has initiated the RECLAIM-LN Phase 2 clinical trial of its off-the-shelf FT819 CAR T-cell therapy in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis. The trial, supported by RMAT designation and FDA pilot programs, aims to enroll about 53 patients and evaluate the therapy's safet…

Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia

Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia

Aurora Mobile Limited (NASDAQ: JG) announced a three-year Memorandum of Understanding with Exabytes, a leading AI-driven digital solutions provider in Southeast Asia, to jointly develop and deploy AI-powered customer engagement solutions. The partnership aims to integrate Aurora Mobile’s AI-first platforms, EngageLab and GPTBots.ai, with Exabytes’ …

Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Quantum BioPharma Ltd. reported a stronger liquidity position with cash and equivalents nearly doubling to $3.65 million and total assets increasing to $9.5 million as of mid-2026. The company reduced operating expenses by over 50% year-over-year while extending its cash runway to at least October 2027. Importantly, the FDA approved Quantum's Inves…

PowerCompute Reports Second Quarter 2026 Financial Results

PowerCompute Reports Second Quarter 2026 Financial Results

PowerCompute, a Nasdaq-listed Bitcoin mining and treasury company, reported Q2 2026 revenue growth of 9.8% year-over-year driven by increased Bitcoin mining production despite lower Bitcoin prices. The company expanded strategically into high-performance computing (HPC) and AI infrastructure leveraging its power assets and entered into a GPU comput…

UTStarcom Reports Unaudited Financial Results for First Half of 2026

UTStarcom Reports Unaudited Financial Results for First Half of 2026

UTStarcom Holdings Corp. reported unaudited financial results for the first half of 2026 showing a 26.1% decline in revenue to $3.4 million and an increased net loss of $5.1 million compared to $3.7 million in the prior year period. The company is advancing its Optical Circuit Switching (OCS) technology for AI data center networking and continues t…

Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data

Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data

Diginex Limited announced an amended agreement for the acquisition of Resulticks Global Companies Pte. Limited, combining Diginex's ESG and sustainability compliance solutions with Resulticks' AI-powered customer engagement technology. The all-share deal values Resulticks at $1.05 billion, with its shareholders becoming majority owners of the combi…

Kodiak AI Receives DMV Permit to Test Autonomous Trucks in California

Kodiak AI Receives DMV Permit to Test Autonomous Trucks in California

Kodiak AI, a Nasdaq-listed leader in autonomous vehicle technology, announced it received a drivered testing permit from the California DMV under new regulations allowing heavy-duty autonomous vehicles to test on public roads. This permit enables Kodiak to begin scaling its autonomous trucking operations across the U.S., starting with California, m…

SFL - Invitation to Presentation of Q2 2026 Results

SFL - Invitation to Presentation of Q2 2026 Results

SFL Corporation Ltd., a maritime industry company listed on the NYSE, will release its preliminary financial results for Q2 2026 on August 26, 2026, followed by a webcast and conference call for investors and analysts. The company has a diversified fleet and a history of consistent quarterly dividends. The announcement includes forward-looking stat…

Diversified Energy Response to Media Speculation

Diversified Energy Response to Media Speculation

Diversified Energy Company addresses recent media speculation about a potential transaction involving the company. The firm confirms ongoing preliminary discussions regarding a possible acquisition of Birch Resources. No agreement has been reached and there is no certainty that a transaction will proceed. The company emphasizes its disciplined acqu…

Western Union and Intermex Provide Update on Pending Acquisition

Western Union and Intermex Provide Update on Pending Acquisition

Western Union and Intermex provided an update on Western Union's pending acquisition of Intermex, highlighting recent regulatory developments. While the New York State Department of Financial Services approved the transaction with commitments, the California Department of Financial Protection and Innovation has suspended its prior approval to condu…